The following lists Aytu BioScience's accounts (pages) on major social platforms, including Facebook, Twitter, Instgram, LinkedIn, etc. You can find the support information (solution) of related problems through these social pages, and you can also use Aytu BioScience's support phone number, support email, or direct access to all Aytu BioScience customer service contacts.
Aytu BioScience Overview
Aytu BioPharma (NASDAQ: AYTU) is a dynamic pharmaceutical company with a growing commercial portfolio of prescription medicines addressing complex conditions, with a focus on ADHD and other pediatric illnesses. Our evolution has been driven by strategic in-licensing, acquisition-based transactions and organic product growth. As we continue on this trajectory, we’re building a therapeutic pipeline focused on rare pediatric-onset diseases.
Our pipeline is highlighted by AR101/enzastaurin, a well-characterized small molecule targeting the treatment of vascular Ehlers-Danlos Syndrome (VEDS). VEDS is a rare, genetic, life-shortening disease causing catastrophic aortic events and resulting in severe morbidity and death. There are no approved treatments for VEDS. AR101/enzastaurin received Orphan Drug designation from U.S. FDA December of 2021.
| Industry | Pharmaceutical Manufacturing |
| Headquarters | Englewood, CO |
| Company size | 51-200 employees |
| Website | https://aytubio.com |